MUMBAI: The initial public offer of 38.20 lakh equity shares of Anu’s Laboratories opens for subscription on Monday. The company has fixed a price band of Rs 200-Rs 210 per share. The issue will close on May 15.
The issue comprises reservation of upto 2,00,000 equity shares for employees and a net issue to the public of 36,20,000 equity shares. The issue constitutes 31.63 per cent of the fully diluted post issue paid-up capital of the company.
The company plans to utilize the proceeds for – setting up a new plant for manufacturing of drug intermediates including active pharmaceutical ingredients at Vishakhapatnam, setting up of pilot plant for carrying out contract research and manufacturing at Vishakhapatnam, for long term working capital requirement, general corporate purposes and for issue expenses.
ICRA has assigned Grade "2/5" to the IPO. The shares will be listed on Bombay Stock Exchange. The book running lead manager to the issue is Almondz Global Securities.
The issue comprises reservation of upto 2,00,000 equity shares for employees and a net issue to the public of 36,20,000 equity shares. The issue constitutes 31.63 per cent of the fully diluted post issue paid-up capital of the company.
The company plans to utilize the proceeds for – setting up a new plant for manufacturing of drug intermediates including active pharmaceutical ingredients at Vishakhapatnam, setting up of pilot plant for carrying out contract research and manufacturing at Vishakhapatnam, for long term working capital requirement, general corporate purposes and for issue expenses.
ICRA has assigned Grade "2/5" to the IPO. The shares will be listed on Bombay Stock Exchange. The book running lead manager to the issue is Almondz Global Securities.
No comments:
Post a Comment